Skip to main content


Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology OnlineFirst articles

16.08.2018 | Review Article

Liposomal therapies in oncology: does one size fit all?

Liposomal therapies opened the chapter of nanomedicine, in 1995, with the approval of liposomal doxorubicin (Doxil®) for the treatment of numerous types of cancer. For the first time, liposomes permitted the employment of potent chemotherapeutic …

13.08.2018 | Original Article

A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity

Platinum-based agents, such as cisplatin, carboplatin, and oxaliplatin, are the major chemotherapeutic drugs used in the treatment of cancers in the gastrointestinal tract (gastric cancer, colorectal cancer, pancreatic cancer), genitourinary …

13.08.2018 | Original Article

In vitro UGT1A1 inhibition by tyrosine kinase inhibitors and association with drug-induced hyperbilirubinemia

Tyrosine kinase inhibitor (TKI) drugs are a type of targeted therapy that attacks specific types of cancer cells while causing less damage to normal cells. Although TKIs have dramatically increased survival for patients with certain types of …

13.08.2018 | Original Article

Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy

Chemotherapy is a systemic treatment that, while beneficial in the management of malignancies, has several side effects [ 1 ]. The side effects of chemotherapy are divided into three categories according to the time of occurrence: immediate …

13.08.2018 | Short Communication

Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071)

Gastric cancer (GC) is among the most common malignancies worldwide, and remains a highly lethal disease [ 1 ]. Median progression-free survival (PFS) and overall survival (OS) times for unresectable advanced or metastatic gastric cancer (AGC) …

Aktuelle Ausgaben

Über diese Zeitschrift

Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials.

The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.

Weitere Informationen

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.